13F History
Schedule 13D/G History
Ownership
Other Reports

BAKER BROS. ADVISORS LP - Significant Ownership

Signature - Title: Alexandra Toohey - Chief Financial Officer
Location: New York, NY
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by BAKER BROS. ADVISORS LP.

Significant Ownership of BAKER BROS. ADVISORS LP

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
KALA	KALA BIO, Inc.	Common Stock, $0.001 par value per share	19.7%	$8.35M		1.2M		Baker Bros. Advisors LP	Dec 29, 2024
DBVT	DBV Technologies S.A.	Ordinary shares, nominal value 0.10 euro per share	17.1%	$124M		23.5M		Baker Bros. Advisors LP	Mar 27, 2025
SERA	Sera Prognostics, Inc.	Class A Common Stock, $0.0001 par value per share	16.1%	$22.2M		5.5M		Baker Bros. Advisors LP	Feb 12, 2025
REPL	Replimune Group, Inc.	Common Stock, $0.001 par value per share	14.3%	$134M		11M		Baker Bros. Advisors LP	Mar 7, 2025
CELC	Celcuity Inc.	Common Stock, par value $0.001 per share	7.2%	$26.9M		2.68M		Baker Bros. Advisors LP	Dec 31, 2024
CADL	Candel Therapeutics, Inc.	Common Stock, par value $0.01 per share	6.8%	$24.1M		2.98M		Baker Bros. Advisors LP	Dec 31, 2024
IMTX	Immatics N.V.	Ordinary Shares, nominal value (euro)0.01 per share	6%	$33.1M		7.28M		Baker Bros. Advisors LP	Dec 31, 2024
BMEA	Biomea Fusion, Inc.	Common Stock, par value $0.0001 per share	4%	$3.57M		1.45M		Baker Bros. Advisors LP	Dec 31, 2024

Showing 1 to 8 of 8 entries

Schedules 13D/G Reported by BAKER BROS. ADVISORS LP:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Date Filed
DBVT	DBV Technologies S.A.	Ordinary shares, nominal value 0.10 euro per share	17.1%		23.5M		$124M	Baker Bros. Advisors LP	13D/A	3/27/2025	3/31/2025
REPL	Replimune Group, Inc.	Common Stock, $0.001 par value per share	14.3%		11M		$134M	Baker Bros. Advisors LP	13D	3/7/2025	3/7/2025
SERA	Sera Prognostics, Inc.	Class A Common Stock, $0.0001 par value per share	16.1%		5.5M		$22.2M	Baker Bros. Advisors LP	13D	2/12/2025	2/14/2025
IMTX	Immatics N.V.	Ordinary Shares, nominal value (euro)0.01 per share	6%		7.28M		$33.1M	Baker Bros. Advisors LP	13G/A	12/31/2024	2/14/2025
CELC	Celcuity Inc.	Common Stock, par value $0.001 per share	7.2%		2.68M		$26.9M	Baker Bros. Advisors LP	13G/A	12/31/2024	2/14/2025
CADL	Candel Therapeutics, Inc.	Common Stock, par value $0.01 per share	6.8%		2.98M		$24.1M	Baker Bros. Advisors LP	13G	12/31/2024	2/14/2025
BMEA	Biomea Fusion, Inc.	Common Stock, par value $0.0001 per share	4%		1.45M		$3.57M	Baker Bros. Advisors LP	13G/A	12/31/2024	2/14/2025
KALA	KALA BIO, Inc.	Common Stock, $0.001 par value per share	19.7%		1.2M		$8.35M	Baker Bros. Advisors LP	13D/A	12/29/2024	12/31/2024

Showing 1 to 8 of 8 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.